News | November 13, 2024
Cupid Q2 FY25 income up 29.7%; PAT up 96.2%
Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%
Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%
Construction of the plant will commence in 2025 with first production expected to be in 2027
These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
The acquisition will strengthen the overall company’s position as leading global CRO services partner
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Subscribe To Our Newsletter & Stay Updated
